. Suppaluek Na Songkla, Mr. Ittidet Phonin and Miss Nittaya Na Songkla offered company to buy SUTG stock for 132,000 units whereas 66% of total paid-up capital of SUTG. Main reason of the deal is to come back
deal, Aapico ITS Co., Ltd. (“AITS”) needs to sell its 60 percent equity in Aapico QI Sdn. Bhd. (“AQI”) in Malaysia for an amount of SGD 450,000. The Company had to make this sale for the reason that QI’s
purchasing to deal with new suppliers for better deal in term of better price, volume and credit term. Page 2 of 3 Selling and Admin Expenses % Selling and admin expenses to revenue of Q3 2017 and Q3 2016 are
part of the deal, Aapico ITS Co., Ltd. (“AITS”), a 60 percent subsidiary of the Company, needs to sell its 60 percent equity in Aapico QI Sdn. Bhd. (“AQI”) in Malaysia for an amount of SGD 450,000. The
51.31% to 50.92%. However, the Company continues to closely monitor to reduce the food waste and for purchasing to deal with new suppliers for better deal in term of better price, volume and credit term
system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht
(12) clients’ asset An intermediary shall arrange adequate protection for clients’ assets when it is responsible for them; (13) relations with regulators An intermediary shall deal with relevant
intermediary shall arrange adequate protection for clients’ assets when it is responsible for them; (13) relations with regulators An intermediary shall deal with relevant regulators in utterly cooperative way
Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including
and Drug Administration (CFDA), which took around 2 months, that we have got CFDA in early 2018. Sales by product category Consolidated financial statements For the three months period ended March 31